D.E. Shaw & Co’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-65,743
Closed -$27.6K 5033
2022
Q4
$27.6K Sell
65,743
-102,343
-61% -$103K ﹤0.01% 4493
2022
Q3
$164K Buy
168,086
+13,119
+8% +$23.2K ﹤0.01% 4518
2022
Q2
$451K Sell
154,967
-74,673
-33% -$314K ﹤0.01% 4152
2022
Q1
$1.73M Buy
229,640
+119,816
+109% +$992K ﹤0.01% 3442
2021
Q4
$1.53M Buy
109,824
+58,377
+113% +$1.15M ﹤0.01% 3587
2021
Q3
$1.33M Buy
+51,447
New +$1.63M ﹤0.01% 3383

Other funds holding AMTI

D.E. Shaw & Co's AMTI Position: Q1 2023 in Review

D.E. Shaw & Co sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q1 2023, closing a stake of 65,743 shares — an estimated $27.6K sold.

D.E. Shaw & Co first reported a position in AMTI in Q3 2021 and held it in 6 quarters. The position peaked at $1.73M in Q1 2022. 35 funds tracked by Wall St. Rank hold AMTI as of Q1 2023.

  • D.E. Shaw & Co reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 65,743 Applied Molecular Transport Inc. Common Stock shares in Q1 2023, an estimated $27.6K.
  • D.E. Shaw & Co first reported a position in Applied Molecular Transport Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • D.E. Shaw & Co's Applied Molecular Transport Inc. Common Stock position peaked at $1.73M in Q1 2022.
  • 35 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.